Open AccessImmune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review)
Author(s) -
Silvia Vivarelli,
Luca Falzone,
Francesco Torino,
Giuseppa Scandurra,
Giulia Russo,
Roberto Bordonaro,
Francesco Pappalardo,
Demetrios A. Spandidos,
G. Raciti,
Massimo Libra
Publication year - 2020
Publication title -
international journal of oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.405
H-Index - 122
ISSN - 1019-6439
DOI - 10.3892/ijo.2020.5159
Subject(s) - lymphocytopenia , immune system , immunology , nivolumab , medicine , cancer , immune checkpoint , disease , antibody , pneumonia , coronavirus , covid-19 , infectious disease (medical specialty) , immunotherapy , lymphocyte